BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8270966)

  • 1. Intravesical therapy for superficial bladder cancer: is it a wash?
    Kilbridge KL; Kantoff P
    J Clin Oncol; 1994 Jan; 12(1):1-4. PubMed ID: 8270966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Superficial bladder cancer: prophylaxis of recurrence and progression].
    Miyanaga N; Akaza H; Koiso K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical mitozantrone in recurrent superficial bladder cancer.
    Newling DW
    Br J Urol; 1995 Dec; 76(6):814. PubMed ID: 8535743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer].
    Chinese Urological Oncology Group
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):42-45. PubMed ID: 30678415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study.
    Stavropoulos NE; Hastazeris K; Filiadis I; Mihailidis I; Ioachim E; Liamis Z; Kalomiris P
    Scand J Urol Nephrol; 2002; 36(3):218-22. PubMed ID: 12201939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?].
    Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF
    Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic treatment of superficial bladder tumor.
    Lee C; Park MS
    Int J Urol; 1998 Nov; 5(6):511-20. PubMed ID: 9855117
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life in patients undergone oncopreventive intravesical treatment for superficial bladder cancer.
    Abbona A; Morabito F; Rossi R; Billia M; Liberale F; Ferrando U
    Arch Ital Urol Androl; 2007 Dec; 79(4):143-6. PubMed ID: 18303728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of prophylactic intravesical instillation of pirarubicin to prevent recurrent bladder tumors following nephroureterectomy for upper urinary tract cancer].
    Nagashima M; Araki A; Yanagisawa M; Komiya A; Takano T; Murakami T; Ikeda I
    Hinyokika Kiyo; 2013 Apr; 59(4):213-6. PubMed ID: 23635455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral administration of 5-fluorouracil (5-FU) with intravesical chemotherapy as prophylaxis against recurrence of superficial bladder tumors].
    Tanaka T; Yuasa M; Yamamoto A; Kawanishi Y; Numata A; Imagawa A
    Gan No Rinsho; 1986 Sep; 32(11):1439-42. PubMed ID: 3773272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical chemotherapy of superficial bladder tumors].
    Matsumura Y
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S; Akaza H; Ohashi Y; Kotake T
    Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK
    Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
    Mouracade P
    J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904
    [No Abstract]   [Full Text] [Related]  

  • 19. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
    Ayres BE; Crew JP;
    BJU Int; 2010 Feb; 105 Suppl 2():14-7. PubMed ID: 20089093
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.